Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
February 12, 2008
from PR Newswire
BioDelivery Sciences to Present BEMA(TM) Fentanyl Data at the 24th Annual Meeting of the American Academy of Pain Medicine
February 11, 2008
from PR Newswire
Cephalon General Counsel John E. Osborn to Resign Position
February 08, 2008
from PR Newswire
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
January 25, 2008
from PR Newswire
Cephalon's EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
January 24, 2008
from PR Newswire
Cephalon Quarterly Conference Call Invitation
January 08, 2008
Fourth Quarter & Full Year 2007 Earnings Conference Call Tuesday, February 12, 2008, 5:00 p.m. U.S. EST Read More
from PR Newswire
Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
January 07, 2008
from PR Newswire
from PR Newswire
Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
December 31, 2007
from PR Newswire
TREANDA Significantly Improves Clinical Outcomes in Patients with Chronic Lymphocytic Leukemia Compared to Chlorambucil
December 10, 2007
Data from Pivotal Study Show Bendamustine Produced a Significant Increase in Overall Response Rate and Progression Free Survival Read More
from PR Newswire
TREANDA Demonstrates Substantial Efficacy in Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
December 10, 2007
from PR Newswire
TREANDA New Drug Application for the Treatment of Chronic Lymphocytic Leukemia Granted Priority Review Status by FDA
December 03, 2007
from PR Newswire
Cephalon Submits Supplemental New Drug Application for FENTORA
November 12, 2007
Indication Sought for Breakthrough Pain Associated with Chronic Pain Conditions in Patients Who are Already Taking Opioid Medications Around-the-Clock Read More
from PR Newswire
Cephalon Announces Strong Third Quarter Financial Results
November 08, 2007
from PR Newswire
Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
November 01, 2007
from PR Newswire
Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkin's Lymphoma
October 23, 2007
from PR Newswire
Cephalon Quarterly Conference Call Invitation
October 01, 2007
Third Quarter 2007 Earnings Conference Call Thursday, November 8, 2007, 5:00 p.m. U.S. EST Read More
from PR Newswire
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
September 21, 2007
from PR Newswire
Breaking Stock Alert for Wednesday: RBRM! September 19, 2007
September 19, 2007
Cephalon Announces Completion of Anticipated PROVIGIL Label Updates
September 17, 2007
from PR Newswire
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
September 13, 2007
from PR Newswire
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
August 29, 2007
from PR Newswire
from PR Newswire
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
August 23, 2007
from PR Newswire
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
August 16, 2007
from PR Newswire
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here